-->
Left atrial appendage closure devices market was valued at US$ 1.98 billion in 2024 and is projected to hit the market valuation of US$ 9.40 billion by 2033 at a CAGR of 18.9% during the forecast period 2025–2033.
Organ care products market was valued at US$ 199.20 million in 2024 and is projected to hit the market valuation of US$ 812.12 million by 2033 at a CAGR of 16.90% during the forecast period 2025–2033.
Gynecological devices market was valued at US$ 10.18 billion in 2024 and is projected to hit the market valuation of US$ 20.19 billion by 2033 at a CAGR of 7.90% during the forecast period 2025–2033.
Tissue Factor Pathway Inhibitor (TFPI) ELISA kits market was valued at US$ 148.1 million in 2024 and is projected to hit the market valuation of US$ 301.0 million by 2033 at a CAGR of 8.50% during the forecast period 2025–2033.
Stroke diagnostic and therapeutic market was valued at US$ 42.07 billion in 2024 and is projected to hit the market valuation of US$ 81.68 billion by 2033 at a CAGR of 7.65% during the forecast period 2025–2033.
Ambulatory surgical centers market was valued at US$ 85.9 billion in 2024 and is projected to hit the market valuation of US$ 142.6 billion by 2033 at a CAGR of 5.8% during the forecast period 2025–2033.
Vacuum blood collection tube market was valued at US$ 3.24 billion in 2024 and is projected to hit the market valuation of US$ 4.40 billion by 2033 at a CAGR of 3.45% during the forecast period 2025–2033.
Automated immunoassay analyzers market was valued at US$ 23.12 billion in 2024 and is projected to hit the market valuation of US$ 74.59 billion by 2033 at a CAGR of 13.90% during the forecast period 2025–2033.
Japan point-of-care testing market was valued at US$ 2,361.59 million in 2024 and is projected to hit the market valuation of US$ 4,557.56 million by 2033 at a CAGR of 7.91% during the forecast period 2025–2033.